- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Hengrui Therapeutics, Inc.
Total 2966 results
-
VA Office of Research and DevelopmentHelsinn Therapeutics (U.S.), IncTerminated
-
Johns Hopkins UniversityJuvenile Diabetes Research Foundation; iCo Therapeutics Inc.TerminatedDiabetic Macular EdemaUnited States
-
Radboud University Medical CenterDutch Heart Foundation; Synvista Therapeutics, IncCompletedCardiovascular Disease | Physical Activity | Aging | Endothelial DysfunctionNetherlands
-
Johns Hopkins UniversityNational Multiple Sclerosis Society; Axsome Therapeutics, Inc.Not yet recruitingMultiple Sclerosis | Multiple Sclerosis Fatigue
-
The Affiliated People's Hospital of Ningbo UniversityUTC Therapeutics Inc.RecruitingLymphoma | Leukemia | Myeloma | Relapsed/Refractory Hematological MalignanciesChina
-
Rahul AggarwalFortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
AlaMab Therapeutics (Shanghai) Inc.CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
Cellphire Therapeutics, Inc.U.S. Army Medical Research and Development CommandRecruitingCardiac SurgeryUnited States
-
Jeff C. Huffman, MDBioXcel Therapeutics IncWithdrawn
-
Allarity TherapeuticsSmerud Medical Research International AS; Lantern Pharma Inc.Active, not recruitingIrofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)Metastatic Castration-Resistant Prostate Cancer PatientsDenmark
-
Y-mAbs TherapeuticsInvicro; Labcorp Corporation of America Holdings, IncWithdrawn
-
Merit E. Cudkowicz, MDDenali Therapeutics Inc.Enrolling by invitation
-
Guru P. SonpavdeQED Therapeutics, Inc.WithdrawnBladder Cancer | Bladder Transitional Cell Carcinoma | Fibroblast Growth Factor Receptor
-
Tulane University School of MedicineKaryopharm Therapeutics IncWithdrawnRefractory Multiple Myeloma | Relapsed Multiple Myeloma
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Pain TherapeuticsNational Institute on Aging (NIA)Completed
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Ception TherapeuticsCephalonCompletedEosinophilic EsophagitisUnited States, Canada
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
Motus Therapeutics, Inc.Michael J. Fox Foundation for Parkinson's ResearchTerminatedParkinson's DiseaseUnited States
-
Ception TherapeuticsCephalonCompletedAsthmaUnited States, Canada
-
Iworks Laser and Vision CenterOcular Therapeutix, Inc.Completed
-
Retina Vitreous Associates of FloridaOcular Therapeutix, Inc.TerminatedDiabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular DegenerationUnited States
-
Massachusetts Eye and Ear InfirmaryOcular Therapeutix, Inc.WithdrawnGraft Vs Host DiseaseUnited States
-
Ophthalmic Consultants of Long IslandOcular Therapeutix, Inc.UnknownPatient PreferenceUnited States
-
Mitchel IbachOcular Therapeutix, Inc.Not yet recruiting
-
Clinical Research Center of FloridaOcular Therapeutix, Inc.CompletedBilateral Conjunctivitis (Disorder)United States
-
Nathan SteinleOcular Therapeutix, Inc.UnknownOcular Disease Requiring SurgeryUnited States
-
Rempex (a wholly owned subsidiary of Melinta Therapeutics...Department of Health and Human ServicesRecruitingBacterial InfectionsUnited States
-
University of ColognePfizer; F2G Biotech GmbH; Basilea Pharmaceutica; Cidara Therapeutics Inc.; Matinas...RecruitingInvasive Fungal DiseaseGermany
-
Modulation Therapeutics, Inc.H. Lee Moffitt Cancer Center and Research InstituteRecruitingUveal Melanoma | MetastaticUnited States
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
IVI VigoInstituto Valenciano de Infertilidad, IVI VALENCIA; Juno Therapeutics, Inc.Not yet recruiting
-
Barbara Parker, MDOncternal Therapeutics, IncCompletedBreast NeoplasmsUnited States
-
Alice MimsKaryopharm Therapeutics IncCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Kari KendraKaryopharm Therapeutics IncCompletedRecurrent MelanomaUnited States
-
Insight Therapeutics, LLCBrown University; Genentech, Inc.; Case Western Reserve UniversityActive, not recruitingInfluenza | Influenza, Human | Influenza -Like IllnessUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedMultiple MyelomaUnited States
-
University of North Carolina, Chapel HillMidmark Corporation; Monitored Therapeutics, IncCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteKaryopharm Therapeutics IncCompletedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Karyopharm Therapeutics IncCompletedAcute Myeloid Leukemia | LeukemiaUnited States
-
Imperial College LondonSarepta Therapeutics, Inc.; Department of Health, United KingdomCompletedDuchenne Muscular DystrophyUnited Kingdom
-
Nohla Therapeutics, Inc.National Cancer Institute (NCI); Fred Hutchinson Cancer CenterTerminatedAcute Myeloid Leukemia | Acute Leukemia of Ambiguous LineageUnited States
-
Michael Vogelbaum, MD, PhDInfuseon Therapeutics, Inc.Withdrawn
-
Wake Forest UniversityEKR Therapeutics, IncTerminatedHip ArthroplastyUnited States
-
Michael Vogelbaum, MD, PhDInfuseon Therapeutics, Inc.CompletedMalignant Glioma | WHO Grade III or IV Recurrent GliomaUnited States
-
Erin BertinoKaryopharm Therapeutics IncWithdrawnRecurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma
-
Therapeutic Advances in Childhood Leukemia ConsortiumCompletedAcute Myelogenous LeukemiaUnited States, Canada, Australia